Professional background

2025

The START Center for Cancer Research / XenoSTART · Remote

• Supported external partnership development for XenoSTART preclinical oncology research services, with emphasis on patient-derived xenograft models, translational oncology, and drug development decision-making.

• Managed account and project development plans while tracking progress against relationship, proposal, contract, and study-planning milestones.

• Met with clinical cancer research stakeholders, including oncologists and clinical trial leaders, to connect clinical research needs with preclinical model selection.

• Communicated the translational relevance of patient-derived xenograft models and preclinical oncology platforms to scientific and industry stakeholders.

2024 – 2025

Sales and Business Development Manager, Mid-Atlantic Territory

GemPharmatech · Remote

• Supported client relationships involving genetically engineered mouse models, preclinical research services, and biomedical research applications.

• Communicated technical capabilities to scientific stakeholders across academic, biotech, pharmaceutical, and preclinical research organizations.

2020 – 2024

Executive Director, Gene Editing Solutions

Hera BioLabs, Inc. · Lexington, KY

• Led client-facing project management for cell line engineering, custom gene editing, and transgenic mouse and rat model creation, coordinating scope, timelines, scientific requirements, and internal execution.

• Hired and supervised scientific team members, expanding the gene editing team from 4 to 7 reports to support increased project volume.

• Led the strategic pivot from research-focused cell line creation toward CHO bioprocessing and cell line development service offerings.

• Implemented GLP-like quality controls, SOPs, and documentation practices to improve consistency, traceability, and client-ready project records.

• Oversaw gene editing service development involving CRISPR/Cas9, Cas-CLOVER, and piggyBac transposon-based technologies.

2020 – 2024

Executive Director, Business Development

Hera BioLabs, Inc. · Lexington, KY

• Managed strategic research accounts and ongoing service initiatives with regular communication across scientific, operational, and external stakeholders.

• Coordinated proposal development, pricing strategy, and project planning for preclinical toxicology, pharmacology, oncology, and gene editing services.

• Negotiated commercial and research licensing agreements for gene editing technologies and preclinical research services.

• Created and executed business development and marketing plans that contributed to sustained company growth.

2016 – 2020

Business Development Manager

Hera BioLabs, Inc. · Lexington, KY

• Collaborated with senior scientists to develop proposals for CRO services, including efficacy, pharmacology, toxicology, and gene editing studies.

• Maintained a pipeline of preclinical research service opportunities, including communication, scoping, follow-up, and project development.

• Managed spending, invoicing, and lab supply ordering for two SBIR-funded grant projects, supporting budget tracking and research administration.

2014 – 2016

Technical Sales Specialist

Transposagen Biopharmaceuticals, Inc. · Lexington, KY

• Delivered technical presentations to scientific decision makers on custom genetic engineering and model creation services.

• Managed logistics and marketing for company participation at scientific conferences and trade shows.